PORT WASHINGTON, N.Y. (November 8, 2018)—Drive DeVilbiss Healthcare announced its sponsorship of a symposium at the Latin American Federation of Sleep Society’s 17th annual FLASS Congress, held November 9–11 at the Hotel Enjoy Punta del Este in Uruguay. The symposium, titled “Accreditation in Sleep Medicine-The Latin American Experience,” aimed to focus on the pros and cons of current and soon-to-be-implemented sleep medicine processes needed to strengthen the practice and improve the quality of life for Latin American patients.
According to an article in the Journal of Clinical Sleep Medicine, a study was conducted to determine the most common sleep disorders found in four Latin American countries. At the end of the study, doctors found that there was a high percentage of obstructive sleep apnea not diagnosed in metropolitan areas of Mexico City, Uruguay, Chile and Venezuela. Of the 4,533 subjects studied, 60.2 percent reported snoring, 16.4 percent reported excessive diurnal sleepiness, 12.3 percent reported observed apneas, and 34.7 percent reported insomnia. Sleep therapy through the use of a CPAP device helps address such sleep-related disorders and symptoms.
“Our team is excited to increase awareness and adoption of the IntelliPAP and SleepCube portfolio brands for the treatment of sleep apnea within Latin American countries,” said Wally Haddick, VP of sales, Latin America. “Drive DeVilbiss Healthcare is proud of the industry partnership with FLASS and the sleep community, knowing our support allows the collaboration of sleep professionals at the highest academic levels.”
The event is organized by the Argentine Association of Sleep Medicine (AAMS) and the Sleep Association of Uruguay (ASSUR). It is also academically endorsed by the CLAEH University and declared as a tourist interest by the Ministry of Tourism and Sports of Uruguay. Approximtely 500 participants were expected to attend.
For more information, visit drivemedical.com.
